Press Release


Novotech Awarded Asia-Pacific Biotech CRO of the Year - Announced at ASCO
May 31, 2019 07:00 JST
Novotech, the Asia-Pacific CRO, has again won the prestigious Asia-Pacific CRO of the year awarded by leading analyst firm Frost & Sullivan. This is the fifth year Novotech has been awarded the top CRO for the region which focusses on best practices in clinical research for biotechs.
More info..

Novotech CRO strengthens South Korean Clinical Capabilities, partners with 2 Major Hospitals
Apr 18, 2019 04:00 JST
Novotech, the award-winning Asia-Pacific CRO, with 23 years of experience in the region, has further strengthened its presence in South Korea with two major hospitals joining the Novotech partnership program - bringing more quality investigators, KOLs, and up to 4 million patients.
More info..

Novotech CNS USA Appoints Dr Robert Malone to its Washington, DC BioDesk
Mar 25, 2019 18:00 JST
Clinical Network Services (CNS) USA, an integrated service group focused on clinical product development, a subsidiary of Asia-Pacific specialist CRO Novotech, today announced the appointment of Dr Robert Malone as Principal Consultant in the Washington D.C. office.
More info..

Novotech CRO Launches Largest Oracle Trial Management and Monitoring Cloud Service Implementation in Asia-Pacific
Dec 17, 2018 08:00 JST
Asia-Pacific specialist CRO Novotech announced as part of its ongoing IT infrastructure investment program that it has implemented the Oracle's Trial Management and Monitoring Cloud Service (TMMCS) to support its growth in the Asia-Pacific.
More info..

Novotech CRO Announces 41 Clinical Staff and 81 Projects in South Korea
Nov 28, 2018 11:02 JST
Asia-Pacific specialist CRO Novotech announced today that clinical staff numbers in its Seoul, South Korea centre are now at 41, with 81 clinical research projects now completed.
More info..

Novotech and CNS deal expands CRO services for Biopharma Clients across Asia-Pacific
Oct 19, 2018 07:00 JST
Novotech, the largest Asia-Pacific-based CRO, has acquired Australasian specialist CRO Clinical Network Services (CNS), as part of a mutual mission to expand services to biopharma for early phase product development and clinical research through to later phase regional and global trials.
More info..

Novotech the Asia-Pacific CRO named Top 10 CRO
Aug 23, 2018 13:00 JST
Asia-Pacific specialist CRO Novotech has been selected as one of the Top 10 CROs globally by leading industry media magazine Pharma Tech Outlook.
More info..

Sponsors Recommend Novotech for CRO Leadership Award
Aug 09, 2018 13:00 JST
Asia-Pacific specialist CRO Novotech has been awarded the "Exceeded Customer Expectations" Award by Life Science Leader magazine based on findings from sponsor companies that utilise outsourcing services. In particular, Novotech was recognised for its local market/regulatory knowledge and for meeting timelines.
More info..

Novotech Partners with Asian Eye Institute for Accelerated Ophthalmic Drug and Devices Clinical Trials
Jul 19, 2018 06:00 JST
Asia-Pacific specialist CRO Novotech announced today it has partnered with the Asian Eye Institute Inc (AEI), a private eye center in the Philippines, to facilitate high-quality and rapid feasibility, start-up and recruitment processes for its ophthalmology clients.
More info..

Novotech at DIA18 announces Asia Partnerships on Target to Reach 1.4 Bil Patients
Jun 28, 2018 06:00 JST
Asia-Pacific CRO Novotech announced today at DIA Global Annual Meeting (24-28 June, Boston Convention and Exhibition Center) that it has signed Memorandum of Understandings (MOU) with five of the leading medical institutions in the region.
More info..

Novotech signs MoU with CMUH Taiwan to offer Enhanced Services for Global Trials
Jun 15, 2018 16:30 JST
Asia-Pacific specialist CRO Novotech announced today it has signed a Memorandum of Understanding (MoU) with the China Medical University Hospital (CMUH) in Taiwan to facilitate high-quality and rapid feasibility, start-up and recruitment processes. http://www.cmuh.cmu.edu.tw/
More info..

Novotech Signs MOU with China Medical University Hospital in Taiwan to Offer Enhanced Services for Global Trials
Jun 12, 2018 11:00 JST
Asia-Pacific specialist CRO Novotech announced today it has signed a Memorandum of Understanding (MOU) with the China Medical University Hospital (CMUH) in Taiwan to facilitate high-quality and rapid feasibility, start-up and recruitment processes. http://www.cmuh.cmu.edu.tw/
More info..

Novotech says Federal Budget R&D Tax Support Keeps Australia Globally Competitive for Quality Clinical Trials
May 18, 2018 02:00 JST
Leading Asia Pacific CRO Novotech commended the Turnbull Government's Federal Budget decision to exclude clinical trials activity from a A$4m cap on cash refunds, or any lifetime cap on refunds.
More info..

Novotech signs Central Lab Services Agreement with Sonic Clinical Trials
Jun 23, 2017 08:00 JST
Asia Pacific specialist CRO Novotech announced today it has expanded its business offering to include central lab services through a preferred partnership agreement with Sonic Clinical Trials, an affiliate of international healthcare company, Sonic Healthcare.
More info..

Novotech signs MOU with South Korea's leading medical center, the Asan Medical Center
Apr 18, 2017 10:00 JST
Asia Pacific specialist CRO Novotech announced today it has signed a Memorandum of Understanding (MOU) with South Korea's largest medical institution - The Asan Medical Center's (AMC) Clinical Trial Center. The MOU formalises Novotech's relationship with the internationally-leading medical center and its principal investigators.
More info..

New Research reveals Asia poised as Preferred Destination for Clinical Trials
Mar 09, 2017 11:00 JST
Frost & Sullivan released a white paper, 'Asia: Preferred Destination for Clinical Trials', with Asia Pacific CRO Novotech presenting the findings to an audience of senior biotechnology and pharmaceutical executives in a private event at the Outsourcing in Clinical Trials - West Coast (OCT-WC 2017) conference, held Feb 22-23 in Burlingame, Ca. (USA).
More info..

New Frost & Sullivan research reveals Asia as Preferred Destination for Clinical Trials
Mar 03, 2017 14:00 JST
Frost & Sullivan released its latest white paper, 'Asia: Preferred Destination for Clinical Trials', with Asia Pacific specialist CRO Novotech. Research from the new white paper revealed Asia is quickly becoming a clinical research powerhouse.
More info..

Latest Release


More Latest Release >>